As of the latest Form 4 filed Jul 9, 2026.
What Charles Schwab Corp insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 39 most recent filings for SCHW.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-09 | 2026-07-07 | Craig Jonathan M. MD, Head of Retail Investing | SSale | −21.8K | $102.01 | $2.22M | Yes (planned) | Form 4 ↗ |
| 2026-07-09 | 2026-07-07 | Craig Jonathan M., MD, Head of Retail Investing | MExercise | +21.8K | $46.81 | $1.02M | Yes (planned) | Form 4 ↗ |
| 2026-07-08 | 2026-07-07 | Beatty Jonathan S MD, Head of Advisor Services | SSale | −2.00K | $102.01 | $204K | Yes (planned) | Form 4 ↗ |
| 2026-06-25 | 2026-06-23 | Ellis Stephen A Director | MExercise | +2.26K | $25.11 | $56.7K | No | Form 4 ↗ |
| 2026-06-04 | 2026-06-03 | Verdeschi Michael D CFO | FTax | −6.52K | $87.42 | $570K | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-28 | Wurster Richard A President & CEO | PPurchase | +22.0K | $84.23 | $1.85M | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-26 | Schwab-Pomerantz Carolyn Director | AAward | +1.60K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-26 | Ruffel Charles A. Director | AAward | +1.60K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-26 | Dea Joan Director | AAward | +1.60K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-26 | ADAMS JOHN K JR Director | AAward | +1.60K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-26 | Brown Marianne Catherine Director | AAward | +1.60K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-26 | Ellis Stephen A Director | AAward | +1.60K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-26 | SNEED PAULA A Director | AAward | +1.60K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-26 | Sarin Arun Director | AAward | +1.60K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-26 | DODDS CHRISTOPHER V Director | AAward | +1.60K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-26 | HERRINGER FRANK C Director | AAward | +1.60K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-14 | 2026-05-13 | Sarin Arun Director | SSale | −2.50K | $91.16 | $228K | No | Form 4 ↗ |
| 2026-05-14 | 2026-05-13 | Sarin Arun, Director | MExercise | +7.87K | $28.96 | $228K | No | Form 4 ↗ |
| 2026-05-06 | 2026-05-06 | Schwab Charles R. Co-Chairman | SSale | −109K | $92.01 | $10.1M | No | Form 4 ↗ |
| 2026-05-06 | 2026-05-05 | Schwab-Pomerantz Carolyn Director | SSale | −9.91K | $92.29 | $915K | No | Form 4 ↗ |
| 2026-05-06 | 2026-05-05 | Schwab-Pomerantz Carolyn, Director | MExercise | +9.91K | $31.65 | $314K | No | Form 4 ↗ |
| 2026-05-06 | 2026-05-04 | Schwab Charles R. Co-Chairman | SSale | −109K | $91.50 | $10.0M | No | Form 4 ↗ |
| 2026-05-01 | 2026-05-01 | Schwab Charles R. Co-Chairman | SSale | −55.0K | $91.86 | $5.05M | No | Form 4 ↗ |
| 2026-05-01 | 2026-04-30 | Schwab Charles R., Co-Chairman | SSale | −50.0K | $91.81 | $4.59M | No | Form 4 ↗ |
| 2026-05-01 | 2026-04-29 | Schwab Charles R., Co-Chairman | SSale | −63.7K | $90.49 | $5.77M | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | HERRINGER FRANK C Director | SSale | −2.52K | $90.60 | $228K | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | HERRINGER FRANK C, Director | MExercise | +7.87K | $28.96 | $228K | No | Form 4 ↗ |
| 2026-04-27 | 2026-04-27 | Schwab Charles R. Co-Chairman | SSale | −36.5K | $90.00 | $3.28M | No | Form 4 ↗ |
| 2026-04-27 | 2026-04-23 | Schwab Charles R., Co-Chairman | SSale | −36.5K | $90.50 | $3.30M | No | Form 4 ↗ |
| 2026-04-16 | 2026-04-15 | Woolway Paul V MD, Chief Banking Officer | SSale | −7.94K | $100.00 | $794K | Yes (planned) | Form 4 ↗ |
| 2026-04-16 | 2026-04-15 | Woolway Paul V, MD, Chief Banking Officer | MExercise | +7.94K | $52.05 | $413K | Yes (planned) | Form 4 ↗ |
| 2026-04-16 | 2026-04-14 | Woolway Paul V, MD, Chief Banking Officer | SSale | −7.94K | $98.00 | $778K | Yes (planned) | Form 4 ↗ |
| 2026-04-16 | 2026-04-14 | Woolway Paul V, MD, Chief Banking Officer | MExercise | +7.94K | $52.05 | $413K | Yes (planned) | Form 4 ↗ |
| 2026-04-15 | 2026-04-14 | Craig Jonathan M. MD, Head of Retail Investing | SSale | −21.8K | $99.00 | $2.15M | Yes (planned) | Form 4 ↗ |
| 2026-04-15 | 2026-04-14 | Craig Jonathan M., MD, Head of Retail Investing | MExercise | +21.8K | $46.81 | $1.02M | Yes (planned) | Form 4 ↗ |
| 2026-04-15 | 2026-04-14 | Murtagh Nigel J Chief Risk Officer | SSale | −41.3K | $99.00 | $4.09M | Yes (planned) | Form 4 ↗ |
| 2026-04-15 | 2026-04-14 | Murtagh Nigel J, Chief Risk Officer | MExercise | +41.3K | $52.05 | $2.15M | Yes (planned) | Form 4 ↗ |
| 2026-03-25 | 2026-03-24 | Ellis Stephen A Director | MExercise | +7.87K | $28.96 | $228K | No | Form 4 ↗ |
| 2026-03-25 | 2026-03-24 | Ellis Stephen A, Director | MExercise | +1.90K | $28.38 | $53.9K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also SCHW’s full analysis or the market-wide insider trading feed. The tabs above jump to SCHW’s other SEC data.
Source: SEC Form 4 filings for SCHW, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.